HeartSciences (HSCS) FCF Margin (2021 - 2025)
HeartSciences (HSCS) posted quarterly FCF Margin of 96497.15% for Q4 2025, up 6.14% on a QoQ basis from 102808.79% in Q3 2025.
HeartSciences (HSCS) FCF Margin (2021 - 2025) Analysis & Trends
HeartSciences (HSCS) has reported FCF Margin for 5 consecutive years, with 96497.15% the latest figure, recorded in Q4 2025.
- Quarterly FCF Margin changed N/A year-over-year to 96497.15% in Q4 2025, while the trailing twelve-month figure through Apr 2026 was 68798.95% (down 2988560.0% YoY) and the FY2026 annual result came in at 172036.61%, down 155038.0% from the prior year.
- FCF Margin advanced to 96497.15% in Q4 2025 per HSCS's latest filing, from 102808.79% in the prior quarter.
- Over the last five years, FCF Margin for HSCS reached as high as 9587.0% in Q3 2021 and fell as low as 102808.79% in Q3 2025.
- A 5-year average of 45853.2% and a median of 35916.03% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 4725534 bps — and 2024, when it soared 3813463 bps.
- Year by year, FCF Margin stood at 9587.0% in 2021, then slumped by 493 bps to 56842.34% in 2022, then surged by 55 bps to 25388.18% in 2023, then surged by 43 bps to 14352.14% in 2024, then tumbled by 572 bps to 96497.15% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 96497.15%, 102808.79%, and 36566.44% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 37.67% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | 2.18% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 6.68% |
| 10 | HeartSciences | 6.62 Mn | 4.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -96,497.15% |
| Jul 31, 2025 | -102,808.79% |
| Apr 30, 2025 | -36,566.44% |
| Jan 31, 2024 | -14,352.14% |
| Oct 31, 2023 | -25,388.18% |
| Jan 31, 2023 | -52,486.77% |
| Jul 31, 2022 | -56,842.34% |
| Apr 30, 2022 | -28,737.58% |
| Jan 31, 2022 | -35,265.62% |
| Jul 31, 2021 | -9,587.00% |